Aspen Pharmacare Cash on Hand 2017-2023 | APNHY
Aspen Pharmacare cash on hand from 2017 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Aspen Pharmacare cash on hand for the quarter ending June 30, 2023 was $0.615B, a 2.11% decline year-over-year.
- Aspen Pharmacare cash on hand for 2023 was $0.615B, a 51.27% increase from 2022.
- Aspen Pharmacare cash on hand for 2022 was $0.407B, a 26.98% decline from 2021.
- Aspen Pharmacare cash on hand for 2021 was $0.557B, a 21.98% increase from 2020.
Aspen Pharmacare Annual Cash on Hand (Millions of US $) |
2023 |
$615 |
2022 |
$407 |
2021 |
$557 |
2020 |
$457 |
2019 |
$633 |
2018 |
$872 |
2017 |
$786 |
2016 |
$756 |
2015 |
$ |
Aspen Pharmacare Quarterly Cash on Hand (Millions of US $) |
2023-06-30 |
$615 |
2022-06-30 |
$407 |
2021-12-31 |
$512 |
2021-06-30 |
$557 |
2020-12-31 |
$629 |
2020-06-30 |
$457 |
2019-06-30 |
$633 |
2018-12-31 |
$690 |
2018-06-30 |
$872 |
2017-12-31 |
$625 |
2017-06-30 |
$786 |
2016-12-31 |
$682 |
2016-06-30 |
$756 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$5.328B |
$2.296B |
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|